Biotech

All Articles

Vaxcyte rises on 'impressive' 31-valent PCV gain against Pfizer

.Vaxcyte unveiled what professionals referred to as "sensational" period 1/2 data for its 31-valent ...

Recursion's brain ailment trial reveals little documentation of efficiency

.Recursion has actually discovered by means of an early examination of its tech-enabled technique to...

Acepodia, Pfizer click on together for chemistry-based cell treatment

.Contact it a case of excellent chemical make up: Acepodia, a biotech based upon Nobel Prize-winning...

Praxis epilepsy drug decreases seizures in stage 2 hearing

.Praxis Accuracy Medicines has scored yet another midphase succeed in epilepsy this year, along with...

Three directors resign as Dyne posts blended information for DMD prospect

.After getting away from a medical grip several years back, Dyne Rehab has actually uncovered brand-...

Arrowhead fires off stage 3 information in uncommon metabolic ailment before market clash with Ionis

.Arrowhead Pharmaceuticals has actually shown its give before a possible showdown with Ionis, publis...

Pfizer, Valneva present lyme condition try successful for second booster

.Pfizer and also Valneva may possess about two more years to stand by prior to they produce the init...

Fierce Biotech Editor-in-Chief Ayla Ellison Talks Patronize Michelle Benz on the Future of Biotech.

.Allow's dive into a talk with Ayla Ellison, Strong Biotech Managing Editor as well as Michelle Benz...

New records show how Bayer's asundexian neglected to avoid strokes

.Bayer put on hold the period 3 test for its own factor XIa inhibitor asundexian behind time in 2013...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is still bented on taking its own several sclerosis (MS) med tolebrutinib to the FDA, manage...